Annual D&A
$843.00 K
-$444.00 K-34.50%
31 December 2023
Summary:
Cartesian Therapeutics annual depreciation & amortization is currently $843.00 thousand, with the most recent change of -$444.00 thousand (-34.50%) on 31 December 2023. During the last 3 years, it has risen by +$109.00 thousand (+14.85%). RNAC annual D&A is now -34.50% below its all-time high of $1.29 million, reached on 31 December 2022.RNAC Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$286.00 K
+$90.00 K+45.92%
01 September 2024
Summary:
Cartesian Therapeutics quarterly depreciation & amortization is currently $286.00 thousand, with the most recent change of +$90.00 thousand (+45.92%) on 01 September 2024. Over the past year, it has increased by +$97.00 thousand (+51.32%). RNAC quarterly D&A is now -36.73% below its all-time high of $452.00 thousand, reached on 01 June 2015.RNAC Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$937.00 K
+$97.00 K+11.55%
01 September 2024
Summary:
Cartesian Therapeutics TTM depreciation & amortization is currently $937.00 thousand, with the most recent change of +$97.00 thousand (+11.55%) on 01 September 2024. Over the past year, it has increased by +$125.00 thousand (+15.39%). RNAC TTM D&A is now -35.25% below its all-time high of $1.45 million, reached on 01 September 2022.RNAC TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.5% | +51.3% | +15.4% |
| 3 y3 years | +14.8% | -15.6% | -14.4% |
| 5 y5 years | -13.5% | +71.3% | +32.3% |
RNAC Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -34.5% | +14.8% | -28.7% | +62.5% | -35.3% | +15.4% |
| 5 y | 5 years | -34.5% | +16.1% | -28.7% | +128.8% | -35.3% | +35.0% |
| alltime | all time | -34.5% | +16.1% | -36.7% | +128.8% | -35.3% | +385.5% |
Cartesian Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $286.00 K(+45.9%) | $937.00 K(+11.5%) |
| June 2024 | - | $196.00 K(+7.1%) | $840.00 K(+2.4%) |
| Mar 2024 | - | $183.00 K(-32.7%) | $820.00 K(-2.7%) |
| Dec 2023 | $843.00 K(-34.5%) | $272.00 K(+43.9%) | $843.00 K(+3.8%) |
| Sept 2023 | - | $189.00 K(+7.4%) | $812.00 K(-16.5%) |
| June 2023 | - | $176.00 K(-14.6%) | $973.00 K(-14.8%) |
| Mar 2023 | - | $206.00 K(-14.5%) | $1.14 M(-11.3%) |
| Dec 2022 | $1.29 M(+2.8%) | - | - |
| Dec 2022 | - | $241.00 K(-31.1%) | $1.29 M(-11.1%) |
| Sept 2022 | - | $350.00 K(+1.4%) | $1.45 M(+0.8%) |
| June 2022 | - | $345.00 K(-1.7%) | $1.44 M(+2.9%) |
| Mar 2022 | - | $351.00 K(-12.5%) | $1.40 M(+11.5%) |
| Dec 2021 | $1.25 M(+70.6%) | $401.00 K(+18.3%) | $1.25 M(+14.3%) |
| Sept 2021 | - | $339.00 K(+11.1%) | $1.09 M(+23.0%) |
| June 2021 | - | $305.00 K(+47.3%) | $890.00 K(+25.4%) |
| Mar 2021 | - | $207.00 K(-15.2%) | $710.00 K(-3.3%) |
| Dec 2020 | $734.00 K(+1.1%) | $244.00 K(+82.1%) | $734.00 K(+5.8%) |
| Sept 2020 | - | $134.00 K(+7.2%) | $694.00 K(-4.5%) |
| June 2020 | - | $125.00 K(-45.9%) | $727.00 K(-6.3%) |
| Mar 2020 | - | $231.00 K(+13.2%) | $776.00 K(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $726.00 K(-25.5%) | $204.00 K(+22.2%) | $726.00 K(+2.5%) |
| Sept 2019 | - | $167.00 K(-4.0%) | $708.00 K(-5.1%) |
| June 2019 | - | $174.00 K(-3.9%) | $746.00 K(-24.4%) |
| Mar 2019 | - | $181.00 K(-2.7%) | $987.00 K(+1.2%) |
| Dec 2018 | $975.00 K(+30.0%) | $186.00 K(-9.3%) | $975.00 K(+0.3%) |
| Sept 2018 | - | $205.00 K(-50.6%) | $972.00 K(+2.5%) |
| June 2018 | - | $415.00 K(+145.6%) | $948.00 K(+27.4%) |
| Mar 2018 | - | $169.00 K(-7.7%) | $744.00 K(-0.8%) |
| Dec 2017 | $750.00 K(-6.5%) | $183.00 K(+1.1%) | $750.00 K(-9.0%) |
| Sept 2017 | - | $181.00 K(-14.2%) | $824.00 K(0.0%) |
| June 2017 | - | $211.00 K(+20.6%) | $824.00 K(+3.1%) |
| Mar 2017 | - | $175.00 K(-31.9%) | $799.00 K(-0.4%) |
| Dec 2016 | $802.00 K(-23.2%) | $257.00 K(+42.0%) | $802.00 K(+10.9%) |
| Sept 2016 | - | $181.00 K(-2.7%) | $723.00 K(-5.2%) |
| June 2016 | - | $186.00 K(+4.5%) | $763.00 K(-25.9%) |
| Mar 2016 | - | $178.00 K(0.0%) | $1.03 M(-1.4%) |
| Dec 2015 | $1.04 M(+20.8%) | $178.00 K(-19.5%) | $1.04 M(+20.6%) |
| Sept 2015 | - | $221.00 K(-51.1%) | $866.00 K(+34.3%) |
| June 2015 | - | $452.00 K(+134.2%) | $645.00 K(+234.2%) |
| Mar 2015 | - | $193.00 K | $193.00 K |
| Dec 2014 | $864.00 K | - | - |
FAQ
- What is Cartesian Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual D&A year-on-year change?
- What is Cartesian Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly D&A year-on-year change?
- What is Cartesian Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Cartesian Therapeutics?
- What is Cartesian Therapeutics TTM D&A year-on-year change?
What is Cartesian Therapeutics annual depreciation & amortization?
The current annual D&A of RNAC is $843.00 K
What is the all time high annual D&A for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual depreciation & amortization is $1.29 M
What is Cartesian Therapeutics annual D&A year-on-year change?
Over the past year, RNAC annual depreciation & amortization has changed by -$444.00 K (-34.50%)
What is Cartesian Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of RNAC is $286.00 K
What is the all time high quarterly D&A for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly depreciation & amortization is $452.00 K
What is Cartesian Therapeutics quarterly D&A year-on-year change?
Over the past year, RNAC quarterly depreciation & amortization has changed by +$97.00 K (+51.32%)
What is Cartesian Therapeutics TTM depreciation & amortization?
The current TTM D&A of RNAC is $937.00 K
What is the all time high TTM D&A for Cartesian Therapeutics?
Cartesian Therapeutics all-time high TTM depreciation & amortization is $1.45 M
What is Cartesian Therapeutics TTM D&A year-on-year change?
Over the past year, RNAC TTM depreciation & amortization has changed by +$125.00 K (+15.39%)